SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (14586)9/16/2000 11:43:10 AM
From: Bluegreen  Respond to of 17367
 
Excellent points and let us in the future counter Cacaio, Manfred and any other poster with the facts about approving a BIOLOGICAL UNDER SUBPART E GUIDELINES!!!!!!!



To: Robert K. who wrote (14586)9/16/2000 2:23:50 PM
From: Cacaito  Respond to of 17367
 
Rk, NO need for INEFFECTIVE DRUGS in the market as per FDA



To: Robert K. who wrote (14586)9/16/2000 2:31:24 PM
From: Cacaito  Read Replies (2) | Respond to of 17367
 
Check: siliconinvestor.com

Glaxo sue DNA. Mab technology involved.

Maybe part of the reason DNA needs xoma?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News